Predictive Value of Neutrophil-to-Lymphocyte Ratio for Immune Checkpoint Inhibitor-Related Myocarditis Among Patients Treated for Non-Small-Cell Lung CancerOA
Predictive Value of Neutrophil-to-Lymphocyte Ratio for Immune Checkpoint Inhibitor-Related Myocarditis Among Patients Treated for Non-Small-Cell Lung Cancer
Jian Xue;Chuanbin Liu;Jun Shao;Li Wang;Yating Han;Jing Wang;Jinda Wang
Senior Department of Cardiology,The Sixth Medical Center of Chinese PLA General Hospital,Beijing,ChinaWestern Medical Branch of Chinese PLA General Hospital,Beijing,ChinaDepartment of Emergency,The First Medical Center of Chinese PLA General Hospital,Beijing,ChinaDepartment of General Surgery,The First Medical Center of Chinese PLA General Hospital,Beijing,ChinaWestern Medical Branch of Chinese PLA General Hospital,Beijing,ChinaWestern Medical Branch of Chinese PLA General Hospital,Beijing,ChinaDepartment of General Surgery,The First Medical Center of Chinese PLA General Hospital,Beijing,China
biomarkersimmune checkpoint inhibitors-related myocarditisimmunotherapyneutrophil-to-lymphocyte rationon-small-cell lung cancer
biomarkersimmune checkpoint inhibitors-related myocarditisimmunotherapyneutrophil-to-lymphocyte rationon-small-cell lung cancer
《肿瘤学创新（英文）》 2025 (2)
50-57,8
This study was supported by the Young Talent Project of Chinese PLA General Hospital(20230433).
评论